- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02526901
The Born in Guangzhou Cohort Study (BIGCS) (BIGCS)
February 22, 2024 updated by: Xiu Qiu, Guangzhou Women and Children's Medical Center
The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China.
Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life.
Biological samples including blood and tissue samples are also collected from the participants.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Over the past three decades, China is undergoing rapidly economic development.
At the same time, the Western diet and urban lifestyle has been more common than before, which may lead to an increase of incidence of non-communicable chronic diseases, such as diabetes and malignancies.
Notably, the current generation of Chinese adults, particularly those in their middle age or older, were born in an era where hardship and rationing was the norm and witnessed a social and epidemiological transition that might have a profound effect on their present health.
In contrast, the younger generation is raised in relative material abundance, under the influence of traditional Chinese values such as a strong family orientation and an emphasis on academic success.
A birth cohort with would provide an opportunity to examine the short- and long-term effects of exposure in early life on health consequences in this younger generation, in the context of rapid development in China.
Study Type
Observational
Enrollment (Estimated)
30000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xiu Qiu, PhD
- Phone Number: 0086 20 38367160
- Email: qxiu0161@163.com
Study Contact Backup
- Name: Jianrong He, MS
- Phone Number: 0086 20 38367159
- Email: hjr0703@163.com
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510623
- Recruiting
- Guangzhou Women And Children's Medical Center
-
Contact:
- Xiu Qiu, PhD
- Phone Number: 0086 20 38367160
- Email: qxiu0161@163.com
-
Contact:
- Jianrong He, MS
- Phone Number: 0086 20 38367160
- Email: hjr0703@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Pregnant women attending their first routine antenatal examinations (usually around week 16) and their partners and offsrping
Description
Inclusion Criteria:
- Pregnant women with <20 weeks of gestation
- Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center
- Permanent residents or families intended to remain in Guangzhou with their child for ≥3 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
No treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participant with pregnancy outcomes
Time Frame: At delivery
|
Including abortion, stillbirth, live birth, preterm birth, low birth weight and birth defects
|
At delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurodevelopment during early childhood
Time Frame: At age of 3 years
|
Including adaptive, gross motor, fine motor, language, and social function; assessed using Gesell Developmental Schedules and Ages and Stages Questionnaire
|
At age of 3 years
|
|
Weight changes during early childhood
Time Frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
Weight changes from birth, 6 weeks, 6 months, 1 year to 3 years
|
At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
|
Height changes during early childhood
Time Frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
Height changes from birth, 6 weeks, 6 months, 1 year to 3 years
|
At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
|
Changes of body composition during early childhood
Time Frame: At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
Changes of body composition from birth, 6 weeks, 6 months, 1 year to 3 years.
Body composition is assessed using Dual Energy X-Ray Absorptiometry
|
At birth, age of 6 weeks, 6 months, 1 year and 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Xiu Qiu, PhD, Guangzhou Women and Children's Medical Center, China
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
December 31, 2030
Study Registration Dates
First Submitted
August 13, 2015
First Submitted That Met QC Criteria
August 16, 2015
First Posted (Estimated)
August 18, 2015
Study Record Updates
Last Update Posted (Actual)
February 26, 2024
Last Update Submitted That Met QC Criteria
February 22, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011Y2-00025
- 201508030037 (Other Grant/Funding Number: Guangzhou Science and Technology Bureau, Guangzhou, China)
- 201041-E00741 (Other Grant/Funding Number: Guangzhou Science and Technology Bureau, Guangzhou, China)
- 2012J5100038 (Other Grant/Funding Number: Guangzhou Science and Technology Bureau, Guangzhou, China)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown